News Releases

Meet Virtual Phantoms at RSNA 2018

Dr. Peter Caracappa, Virtual Phantoms Chief Technology Officer, will be at the RSNA 2018 meeting in Chicago, IL. He will be available for consultation, and to perform demonstrations of our popular tools VirtualDoseCT and VirtualDoseIR. Set up your appointment to experience the tools and discuss upcoming features! Arrange appointments by email: sales@virtualphantoms.com. See you in...

Read More

Virtual Phantoms has reseller agreements in China and Japan

Interested customers in China and Japan now have local partners to contact to inquire about purchase of subscriptions to VirtualDose!  By engaging with local distributors, customers can access the same VirtualDose product, but be able to interact with trusted companies that understand the local market and can provide fast and understandable front-line support.  Visit their websites to learn more!  ...

Read More

See VirtualDose at RSNA 2017

Virtual Phantoms Chief Technology Officer, Dr. Peter Caracappa, will be at the RSNA 2017 meeting in Chicago, IL, and available for demonstrations of the industry-leading VirtualDoseCT, and the newly released VirtualDoseIR. Set up your appointment to see the tools in action, and get a preview of some exciting new upcoming features! Arrange appointments by email: sales@virtualphantoms.com. See you in...

Read More

Virtual Phantoms, Inc Announces the Release of VirtualDose-IR, a New Tool For Organ Dose Data from Interventional Radiology Procedures

(31st July 2017)  —Virtual Phantoms, Inc of Albany, NY USA today announced the release of VirtualDoseIR, a tool for assessing organ dose from Interventional Radiology procedures.  Like its industry-leading product for computed tomography, VirtualDoseCT, VirtualDoseIR combines a family of anatomically realistic human phantoms, advanced Monte Carlo simulations, and an easy to use web interface to provide realistic calculations of dose to a diverse patient population. Advanced models used for organ dose simulationsVirtual Patient technology, a well-tested family of anatomically correct phantoms, advanced GPU-based Monte Carlo simulation, and innovative SaaS programming techniques, that has made VirtualDoseCT so successful.  It enables users to accurately compute doses to radiosensitive organs for a broad range of the patient population, including those outside the “average” body size, pediatric patients from newborn through adolescence, and patients who are pregnant.   IR – New Tools for a growing trend In recent years, interventional radiology (IR) procedures have expanded beyond the traditional cardiovascular applications to many other specialty areas, and so their overall use has increased significantly, today contributing more than 14% of all medical radiation dose in the US.  Long exposure times can subject patients to acute injuries to the skin and other tissues, but the large accumulated doses pose a long-term radiation risk that can be monitored and managed.  With continued growth, it is likely that regulatory attention will turn to IR in the future.  VirtualDose provides an important tool to understanding and managing IR dose.   “We are very excited to be making this important expansion of the VirtualDose product line.  When we began, CT was far and away received the most attention in terms of patient dose.  In recent years, Interventional Radiology has grown in importance to the point that it has received much more focus,” said Dr. George Xu, founder and CEO of Virtual Phantoms, Inc. “We know that VirtualDoseIR will become an invaluable tool for assessing clinical practice of IR and improving patient safety.”   Useful features for clinical application VirtualDoseIR has been designed with clinical practice in mind.  Our web interface allows the user to easily select the parameters of the procedure setup, including field size, kVp, filtration, position, and direction.  As these are selected, the display updates to provide a visualization of the exam field on the patient to ensure it matches the procedure performed.  And because different machines may track different information, the system will accept x-ray output in terms of Dose-Area-Product or air kerma rate and exposure time (both commonly encountered measurements).     Sample display screens from the VirtualDoseIR software   About VPI   Virtual Phantoms, Inc. was founded in 2009 by faculty members from Rensselaer Polytechnic Institute, in collaboration with the University of Florida, with an exclusive license of the “Virtual Patient” technologies developed from nearly 20 years of research at RPI and UF in the field of nuclear and radiological engineering. Combining a large collection of anatomically accurate models of patients of various ages and sizes and sophisticated “Monte Carlo” simulation methods originally developed for nuclear weapons research at Los Alamos in the 1940s, VPI is recognized as a world leader in the modeling of ionizing radiation, radiation safety, and medical/occupational radiation dosimetry.  For more information about Virtual Phantoms or VirtualDose, visit www.virtualphantoms.com or call or email Peter Caracappa, VPI Chief Technology Officer;  +1 518-421-6931, peter.caracappa@virtualphantoms.com.   Virtual Phantoms, Inc. 1425 Central Ave. PO Box 5681 Albany, New York 12205-5681 +1 (518) 288-8048 Web: www.virtualphantoms.com Email:  info@virtualphantoms.com   Press Release...

Read More

INFINITT Healthcare and Virtual Phantoms, Inc Announce Partnership to Add Organ Dose Data to DoseM Radiation Dose Monitoring Software

(25th July 2017)  — INFINITT Healthcare, of Seoul, Republic of Korea (South Korea), and Virtual Phantoms, Inc of Albany, NY USA announced today that they have entered into a partnership to bring the VirtualDose™CT organ dose tool to the INFINITT radiation dose monitoring solution, DoseM. With this partnership, INFINITT further enhances their software solution for collecting and managing dose data and improving patient safety.         Patient safety in medical imaging is a priority INFINITT DoseM is a web-based radiation dose management system, which automatically extracts, stores, and manages dose information from radiation devices and can be interfaced with hospital information systems (e.g., HIS, EMR, PACS, etc) to make dose information accessible as part of the patient record.  INFINITT DoseM can also automatically collect dose information and manage doses efficiently by using Diagnostic Reference Levels(DRL) information.   Dose tracking has become a high priority in medical imaging as mandates for the capture and analysis of patients’ exposure to ionizing radiation expand. By adding patient organ dose to a tool that enables capture and archiving of dose data from multiple modalities and a variety of vendors, the data necessary for a realistic estimate of cumulative risk from ionizing radiation exposure is finally available. 
   Advanced models are used for organ dose simulations This agreement makes the Virtual Patient technology, a well-tested family of anatomically correct phantoms, advanced GPU-based Monte Carlo simulation, and innovative SaaS programming techniques, available to INFINITT customers.  It enables users to accurately compute doses to radiosensitive organs for a broad range of the patient population, including those outside the “average” body size, and pediatric patients from newborn through adolescence. The VirtualDoseCT calculation engine integrates seamlessly with the DoseM software, providing improved information without extra effort on the part of the user. “We are very happy INFINITT Healthcare has selected the VirtualDose technology to provide organ dose data and improve patient safety and information.  With this, our first partnership with an Asia-based company, we are growing the global impact of VirtualDoseCT” said Dr. George Xu, founder and CEO of Virtual Phantoms, Inc.   Sample display screens from the INFINITT DoseM software   ABOUT INFINITT Healthcare INFINITT Healthcare is a global provider of medical imaging and information systems. Being founded in 2002 and listed on Kosdaq in 2010, the company is driving the advancement of healthcare IT by delivering its award-winning products and services to 5,200+ healthcare institutions in more than 51 countries through its global business units and distributers. In the United States, INFINITT Healthcare products are distributed through INFINITT North America, a wholly-owned subsidiary of INFINITT Healthcare. INFINITT’s enterprise imaging solutions include RIS, PACS, Cardiology Suite, Mammography PACS, Dental PACS and 3D/Advanced Visualization software, all operating on a unified platform. INFINITT PACS has been a category leader in Best in KLAS Awards: Software and Services eight times since 2009: 2009-2012 in the Community Hospital category, 2013 in the Ambulatory category, 2015/2016 in both Community and Ambulatory categories, and in the Community Hospital category again in 2017. For more information, call 877-387-6960 or visit www.infinittna.com.   About VPI Virtual Phantoms, Inc. was founded in 2009 by faculty members from Rensselaer Polytechnic Institute, in collaboration with the University of Florida, with an exclusive license of the “Virtual Patient” technologies developed from nearly 20 years of research at RPI and UF in the field of nuclear and radiological engineering. Combining a large collection of anatomically accurate models of patients of various ages and sizes and sophisticated “Monte Carlo” simulation methods originally developed for nuclear weapons research at Los Alamos in the 1940s, VPI is recognized as a world leader in the...

Read More

Visit our Booth #8025 at AAPM 2017

Virtual Phantoms will be exhibiting at the American Association of Physicists in Medicine (AAPM) annual meeting in Denver, CO – July 30 – August 3, 2017. Find us in Booth #8025 Dr. Peter Caracappa, Chief Technology Officer, and John Crossin, Chief Operating Officer, will be there to show our products and answer your questions. If you would like to schedule an appointment ahead of time, email peter.caracappa@virtualphantoms.com to set up a time. See you in Denver!

Read More